Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Circadian rhythm - mammal | R-HSA-400253 | 0 | cyproheptadine | 2913 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | cyproheptadine | 2913 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | cyproheptadine | 2913 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | oleandomycin | 72493 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | oleandomycin | 72493 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | oleandomycin | 72493 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | oleandomycin | 72493 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | oleandomycin | 72493 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | oleandomycin | 72493 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | oleandomycin | 72493 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | edrophonium chloride | 8307 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | edrophonium chloride | 8307 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | edrophonium chloride | 8307 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | edrophonium chloride | 8307 | drug-path |
| Asthma | R-HSA-444620 | map05310 | edrophonium chloride | 8307 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | edrophonium chloride | 8307 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | edrophonium chloride | 8307 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | edrophonium chloride | 8307 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | edrophonium chloride | 8307 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-860 | None | drug-path |